9.12
4.35%
0.38
Handel nachbörslich:
9.12
Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
7.76%
28.99
|
31.43 | 28.68 | 24.99 | 25.68 |
Operating Income/Loss |
7.76%
-28.99
|
-31.43 | -28.68 | -24.99 | -25.68 |
Nonoperating Income/Loss |
28.44%
3.979
|
3.098 | 3.204 | 2.048 | 1.733 |
Income/Loss From Continuing Operations Before Tax |
11.72%
-25.01
|
-28.33 | -25.48 | -22.94 | -23.95 |
Income/Loss From Continuing Operations After Tax |
11.72%
-25.01
|
-28.33 | -25.48 | -22.94 | -23.95 |
Net Income/Loss
|
11.72%
-25.01
|
-28.33 | -25.48 | -22.94 | -23.95 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,224%
67.35
|
2.0264 | 57.40 | 45.65 | 45.09 |
Diluted Average Shares |
3,224%
67.35
|
2.0264 | 57.40 | 45.65 | 45.09 |
Basic Earnings Per Share |
26.00%
-0.37
|
-0.50 | -0.44 | -0.50 | -0.53 |
Diluted Earnings Per Share |
26.00%
-0.37
|
-0.50 | -0.44 | -0.50 | -0.53 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):